Form 8-K - Current report:
SEC Accession No. 0000950170-25-036822
Filing Date
2025-03-11
Accepted
2025-03-11 07:15:11
Documents
13
Period of Report
2025-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rapp-20250311.htm   iXBRL 8-K 43883
2 EX-99.1 rapp-ex99_1.htm EX-99.1 282754
3 GRAPHIC img173444502_0.jpg GRAPHIC 84910
  Complete submission text file 0000950170-25-036822.txt   568639

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rapp-20250311.xsd EX-101.SCH 26973
15 EXTRACTED XBRL INSTANCE DOCUMENT rapp-20250311_htm.xml XML 5120
Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42121 | Film No.: 25725845
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)